H. Kaffarnik

1.6k total citations
106 papers, 1.1k citations indexed

About

H. Kaffarnik is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, H. Kaffarnik has authored 106 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Surgery and 18 papers in Molecular Biology. Recurrent topics in H. Kaffarnik's work include Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Lipoproteins and Cardiovascular Health (18 papers) and Liver Disease Diagnosis and Treatment (12 papers). H. Kaffarnik is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers), Lipoproteins and Cardiovascular Health (18 papers) and Liver Disease Diagnosis and Treatment (12 papers). H. Kaffarnik collaborates with scholars based in Germany, Switzerland and Austria. H. Kaffarnik's co-authors include Armin Steinmetz, Gerd Utermann, Jürgen E. Schneider, C. Jakobs, D. Klaus, H. Pfeil, P. Zöfel, K. Ehlenz, Thomas Schwartz and K. M. Goebel and has published in prestigious journals such as PEDIATRICS, Journal of Lipid Research and European Journal of Biochemistry.

In The Last Decade

H. Kaffarnik

95 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Kaffarnik Germany	19	522	477	300	186	178	106	1.1k
E Nikkilä Finland	19	757 1.5×	446 0.9×	151 0.5×	157 0.8×	360 2.0×	36	1.4k
Ernst J. Schaefer United States	19	540 1.0×	570 1.2×	253 0.8×	165 0.9×	203 1.1×	22	1.2k
Kenneth B. Pomerantz United States	19	253 0.5×	261 0.5×	361 1.2×	222 1.2×	149 0.8×	37	1.2k
Hans Hoff United States	23	324 0.6×	969 2.0×	437 1.5×	132 0.7×	273 1.5×	76	2.1k
Daniel Brun Canada	14	385 0.7×	424 0.9×	109 0.4×	99 0.5×	209 1.2×	25	873
Mario Maioli Italy	17	429 0.8×	658 1.4×	299 1.0×	139 0.7×	333 1.9×	34	1.6k
Toshitaka TAMAI Japan	13	259 0.5×	392 0.8×	230 0.8×	120 0.6×	268 1.5×	44	890
P.-J. Guillausseau France	15	676 1.3×	351 0.7×	237 0.8×	200 1.1×	109 0.6×	21	1.5k
Fumio Umeda Japan	20	448 0.9×	286 0.6×	350 1.2×	397 2.1×	247 1.4×	78	1.4k
Agnès Sassolas France	21	412 0.8×	388 0.8×	312 1.0×	212 1.1×	412 2.3×	43	1.2k

Countries citing papers authored by H. Kaffarnik

Since Specialization

Citations

This map shows the geographic impact of H. Kaffarnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kaffarnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kaffarnik more than expected).

Fields of papers citing papers by H. Kaffarnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Kaffarnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kaffarnik. The network helps show where H. Kaffarnik may publish in the future.

Co-authorship network of co-authors of H. Kaffarnik

This figure shows the co-authorship network connecting the top 25 collaborators of H. Kaffarnik. A scholar is included among the top collaborators of H. Kaffarnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Kaffarnik. H. Kaffarnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hasse, Christian, A. Zielke, Christian Bruns, et al.. (2009). Influence of somatostatin to biochemical parameters in patients with primary hyperparathyroidism. Experimental and Clinical Endocrinology & Diabetes. 103(6). 391–397.

Steinmetz, Armin, et al.. (2008). Adrenomyeloneuropathie: Eine häufige Ursache des Morbus Addison^*. DMW - Deutsche Medizinische Wochenschrift. 119(10). 327–331.

Schaefer, Juergen R., et al.. (2008). Durch orale Kontrazeptiva induzierte Pankreatitis bei Hyperchylomikronämie-Syndrom. DMW - Deutsche Medizinische Wochenschrift. 120(10). 325–328. 2 indexed citations

Steinmetz, Armin, Thomas Schwartz, Uwe Hehnke, & H. Kaffarnik. (1996). Multicenter Comparison of Micronized Fenofibrate and Simvastatin in Patients with Primary Type IIA or IIB Hyperlipoproteinemia. Journal of Cardiovascular Pharmacology. 27(4). 563–570. 44 indexed citations

Ehlenz, K., H. Schneider, Klaus A. Dugi, et al.. (1991). WELCHE ROLLE SPIELT DAS RENIN-ANGIOTENSIN-ALDOSTERON-SYSTEM (RAAS) IN DER PATHOGENESE DER HYPERTONIE BEIM OBSTRUKTIVEN SCHLAFAPNOE-SYNDROM (OSAS)?. 20(10). 548–550. 2 indexed citations

Kaffarnik, H., et al.. (1990). Purification of human serum amyloid A by anion-exchange fast protein liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 526(1). 203–209. 8 indexed citations

Steinmetz, Armin, et al.. (1990). Low-dose oral contraceptives lower plasma levels of apolipoprotein E. European Journal of Obstetrics & Gynecology and Reproductive Biology. 37(2). 155–162. 5 indexed citations

Steinmetz, Armin, et al.. (1989). Polymorphism of apolipoprotein E influences levels of serum apolipoproteins E and B in the human neonate. European Journal of Clinical Investigation. 19(4). 390–394. 23 indexed citations

Ebel, H., et al.. (1989). A rapid laser immunonephelometric assay for serum amyloid A (SAA) and its application to the diagnosis of kidney allograft rejection. Journal of Molecular Medicine. 67(8). 447–451. 32 indexed citations

10.

Steinmetz, Armin, Véronique Clavey, Ngoc Vu‐Dac, H. Kaffarnik, & Jean‐Charles Fruchart. (1989). Purification of human apolipoprotein A-IV by fast protein liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 487(1). 154–160. 20 indexed citations

11.

Schneider, Jürgen E., et al.. (1988). Apoprotein AII in acute pancreatitis: intriguing improvement in the prediction of fatal outcome. Clinica Chimica Acta. 171(2-3). 305–310. 3 indexed citations

12.

Steinmetz, Armin, et al.. (1988). Ultrasonography of achilles tendons in primary hypercholesterolemia. Atherosclerosis. 74(3). 231–239. 32 indexed citations

13.

Kaffarnik, H., et al.. (1978). [Coronary artery reserve in patients with hyperlipoproteinemias (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 67(7). 481–6. 1 indexed citations

14.

Schneider, Jürgen E., W. Haase, & H. Kaffarnik. (1976). [Field study on the decrease of lipids using etofibrate].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 94(13). 785–90. 1 indexed citations

15.

Kaffarnik, H., et al.. (1975). Einfluß von Ovulationshemmern auf den Glucosestoffwechsel. DMW - Deutsche Medizinische Wochenschrift. 100(34). 1703–1709.

16.

Kaffarnik, H., et al.. (1971). Effect of ethanol on the plasma lipids of persons given diets of equal energy value.. Research in Experimental Medicine. 154(1). 22–35. 3 indexed citations

17.

Rüdiger, Hugo W., et al.. (1970). Transitorische Hämolyse, Hyperlipämie und unspezifische Leberveränderung bei Alkoholabusus (Zieve-Syndrom). Annals of Hematology. 20(3). 178–184. 4 indexed citations

18.

Kaffarnik, H., et al.. (1969). Untersuchungen der Serumlipide w�hrend Schwangerschaft und Wochenbett. Archives of Gynecology and Obstetrics. 207(3). 505–512. 2 indexed citations

19.

Kaffarnik, H., et al.. (1968). [A simple method for the determination of lipase activities].. PubMed. 349(8). 1071–2. 1 indexed citations

20.

Klaus, D., H. Kaffarnik, & H. Pfeil. (1963). Untersuchungen ber die Serum-Angiotensinase: II. Mitteilung Klinische Ergebnisse beim Hochdruck und bei Lebererkrankungen. Journal of Molecular Medicine. 41(8). 380–385. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact